Loading publications…
The last 5 uploaded publications
Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma
Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber, Miho Maeda, Ugne Balaseviciute, Catherine E. Willoughby, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, Miguel Torres‐Martín, Judit Peix, Daniel Geh, Erik Ramón-Gil, Behnam Saberi, Scott L. Friedman, Derek A. Mann, Daniela Sia, Josep M. Llovet (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology, 74(5), pp. 2652-2669, DOI: 10.1002/hep.32023.
Article145 days agoEpigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, Laura Royo, Montserrat Domingo-Sàbat, Jordi Abril‐Fornaguera, Nicholas K. Akers, María Sala, S. Ragull, Magdalena Arnal, Núria Villalmanzo, Stefano Cairo, Alberto Villanueva, Roland Kappler, Marta Garrido, Laura Guerra, Constantino Sábado, Gabriela Guillén, Mar Mallo, David Piñeyro, Maria Vázquez‐Vitali, Olga Kuchuk, María Elena Mateos, Gema Ramírez, Manuel Santamarı́a, Yasmina Mozo, Aroa Soriano, Michael Grotzer, Sophie Branchereau, Nagore García de Andoín, Blanca López‐Ibor, Ricardo López Almaraz, José Antonio Salinas, Bárbara Torres, F Hernández, José Javier Uriz, Monique Fabrè, Julià Blanco, Claudia Paris, Viera Bajčiová, Geneviève Laureys, Helena Masnou, Ariadna Clos, Cristina Beléndez, Catherine Guettier, Lauro Sumoy, Ramón Planas, Mireia Jordà, Lara Nonell, Piotr Czauderna, Bruce Morland, Daniela Sia, Bojan Losic, Marie Annick Buendia, Maria‐Rosa Sarrias, Josep M. Llovet, Carolina Armengol (2020). Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. Journal of Hepatology, 73(2), pp. 328-341, DOI: 10.1016/j.jhep.2020.03.025.
Article145 days agoLiver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice
Dhwanil A. Dalwadi, Laura Torrens, Jordi Abril‐Fornaguera, Roser Pinyol, Catherine E. Willoughby, Jeffrey Posey, Josep M. Llovet, Christian Lanciault, David W. Russell, Markus Grompe, Willscott E. Naugler (2020). Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Molecular Therapy, 29(2), pp. 680-690, DOI: 10.1016/j.ymthe.2020.10.018.
Article145 days agoCabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Roger Esteban-Fabró, Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix, Laura Torrens, Agavni Mesropian, Ugne Balaseviciute, Francesc Miró‐Mur, Vincenzo Mazzaferro, Roser Pinyol, Josep M. Llovet (2022). Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma. Clinical Cancer Research, 28(11), pp. 2449-2460, DOI: 10.1158/1078-0432.ccr-21-2517.
Article145 days agoWNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
Alexander Rialdi, Mary E. Duffy, Alex P. Scopton, Frank Fonseca, Julia N. Zhao, Megan Schwarz, Pedro Molina-Sánchez, Slim Mzoughi, Elisa Arceci, Jordi Abril‐Fornaguera, Austin Meadows, Marina Ruiz de Galarreta, Denis Torre, Kyna Reyes, Yan Ting Lim, Felix Rosemann, Z.M. Khan, Kevin Mohammed, Xuedi Wang, Xufen Yu, Manikandan Lakshmanan, Ravisankar Rajarethinam, Soo Yong Tan, Jian Jin, Augusto Villanueva, Eleftherios Michailidis, Ype P. de Jong, Charles M. Rice, Ivan Marazzi, Dan Hasson, Josep M. Llovet, Radoslaw M. Sobota, Amaia Lujambio, Ernesto Guccione, Arvin C. Dar (2023). WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma. Nature Cancer, 4(8), pp. 1157-1175, DOI: 10.1038/s43018-023-00609-9.
Article145 days ago